StockMarketWire.com - CVS, a UK provider of integrated veterinary services, saw pretax profit decline to £11.7m from £14.1m, as announced in its preliminary results for the year ended 30 June 2019.

Revenue was up 24.2% to £406.5m from £327.3m as like-for-like sales growth for the group increased 5.2%.

The board continues to search for acquisitions and the company has a pipeline of opportunities.

Richard Connell, non executive chairman, commented in his statement:

'The pace of growth in the UK economy may be impacted by Brexit uncertainty, but the veterinary sector has proven to be resilient in past periods of economic downturn and the Board believes CVS is sufficiently resilient to withstand any potential future downturn.'

'The performance of the business was considerably improved in the second half of the financial year and the Board is confident that the Group is well placed to deliver further enhancement in shareholder value in the forthcoming financial year.'





Story provided by StockMarketWire.com